BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9139077)

  • 21. [Detection of human cytomegalovirus in urine by polymerase chain reaction].
    Liao LM; Shi BY; Liang CQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr; 16(2):111-3. PubMed ID: 7781048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
    Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of three PCR assays with antigenaemia and serology for the diagnosis of HCMV infection in thoracic transplant recipients.
    Barber L; Egan JJ; Lomax J; Yonan N; Deiraniya AK; Turner AJ; Woodcock AA; Fox AJ
    J Med Virol; 1996 Jun; 49(2):137-44. PubMed ID: 8991937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection.
    Pairoj W; Srichunrusami C; Chantratita W; Bodhiphala P; Sungkanuparph S; Vibhagool A
    J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S28-34. PubMed ID: 10865403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The polymerase chain reaction as a marker of cytomegalovirus infection in heart transplant recipients].
    Niubò J; Pérez JL; Manito N; García A; Roca J; Martín R
    Med Clin (Barc); 1999 Feb; 112(4):121-4. PubMed ID: 10074629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive factors for cytomegalovirus infection after orthotopic liver transplantation using an ultrasensitive polymerase chain reaction assay.
    Basse G; Esposito L; Mengelle C; Kamar N; Ribes D; Lavayssière L; Pillet A; Suc B; Barange K; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2339-41. PubMed ID: 16980084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
    Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
    Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of the cytomegalovirus by the polymerase chain reaction DNA amplification in a kidney transplanted patient.
    Ergazaki M; Liloglou T; Koffa M; Kostakis A; Haliassos A; Spandidos DA
    In Vivo; 1993; 7(6A):531-4. PubMed ID: 8193272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children].
    Chen F; He Z; Pan S; Ning F; Wang Q; Xiao Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):187-90. PubMed ID: 12196838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplants.
    Arbustini E; Grasso M; Diegoli M; Percivalle E; Grossi P; Bramerio M; Campana C; Goggi C; Gavazzi A; Vigano M
    Am J Clin Pathol; 1992 Aug; 98(2):205-13. PubMed ID: 1324600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Sagedal S; Hartmann A; Rollag H
    Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease.
    Gor D; Sabin C; Prentice HG; Vyas N; Man S; Griffiths PD; Emery VC
    Bone Marrow Transplant; 1998 Mar; 21(6):597-605. PubMed ID: 9543064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.
    de Gast GC; Boland GJ; Vlieger AM; de Weger RA; Verdonck LF; Zwaan FE; Jiwa NM
    Bone Marrow Transplant; 1992 Apr; 9(4):221-5. PubMed ID: 1318140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2003 Jan; 75(2):229-33. PubMed ID: 12548129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation.
    Ghisetti V; Barbui A; Franchello A; Varetto S; Pittaluga F; Bobbio M; Salizzoni M; Marchiaro G
    J Med Virol; 2004 Jun; 73(2):223-9. PubMed ID: 15122796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.